Afsaneh Barzi1, Dawn L Hershman2, Cathee Till3, William E Barlow3, Scott Ramsey4, Heinz-Josef Lenz5, Howard S Hochster6, Joseph M Unger3. 1. Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave. Suite 3440, Los Angeles, CA, 90033, USA. barzi@usc.edu. 2. Columbia University Medical Center, New York, NY, USA. 3. SWOG Statistical Center, Seattle, WA, USA. 4. Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 5. Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave. Suite 3440, Los Angeles, CA, 90033, USA. 6. Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Abstract
To explore the rates of osteoporosis (diagnosis and screening) and fractures in colorectal cancer survivors (CRCS), records of clinical trial enrollees was linked to Medicare. Female/male risk of fracture in CRCS is 74% higher than general population. Less than 30% of male and female CRCS receive osteoporosis screening. Osteoporosis is a significant morbidity in CRCS. INTRODUCTION: In the USA, the population of colorectal cancer survivors (CRCS) is on the rise. Calcium and vitamin D are the common thread between colorectal cancer and osteoporosis. We set to explore the patterns and prevalence of osteoporosis (OP) and osteoporotic fractures (OF) in CRCS who received fluorouracil-based therapy on SWOG trials. METHODS: Data for CRCS from three SWOG phase III treatment trials between 1994 and 2000 (N = 3775) were linked to Medicare claims (N = 1233). OP was identified using ICD9 and HCPCS codes; OF was defined using a more restricted set of codes. We compared patterns of OP, OF, and screening for OP by gender in CRCS. Given the gender disparities in the rates of OP and OF, we used data from the National Health Interview Survey (NHIS) and the National Hospital Discharge Survey (NHDS) to assess the ratio of OF in females and males in general population. RESULTS: Forty-seven percent of females and 15% of men CRCS had OP claims. Female CRCS were more likely than males to have OP (HR = 4.76 [3.77-6.01], p < 0.0001) and OF (HR = 2.64 [2.04-3.42], p < 0.0001). In the general population, the female to male ratio of OF was 1.67 as opposed to 2.90 in CRCS, indicating a significantly larger gender disparity of OF in CRCS (p < 0.001). Only 7% of men and 27% of women CRCS had OP screening. CONCLUSION: Despite a low rate of OP screening, the gender disparity of OF in CRCS is more pronounced than the general population. These findings provide an impetus for studying OP and OF in CRCS.
To explore the rates ofosteoporosis (diagnosis and screening) and fractures in colorectal cancer survivors (CRCS), records of clinical trial enrollees was linked to Medicare. Female/male risk offracture in CRCS is 74% higher than general population. Less than 30% of male and female CRCS receive osteoporosis screening. Osteoporosis is a significant morbidity in CRCS. INTRODUCTION: In the USA, the population ofcolorectal cancer survivors (CRCS) is on the rise. Calcium and vitamin D are the common thread between colorectal cancer and osteoporosis. We set to explore the patterns and prevalence ofosteoporosis (OP) and osteoporotic fractures (OF) in CRCS who received fluorouracil-based therapy on SWOG trials. METHODS: Data for CRCS from three SWOG phase III treatment trials between 1994 and 2000 (N = 3775) were linked to Medicare claims (N = 1233). OP was identified using ICD9 and HCPCS codes; OF was defined using a more restricted set of codes. We compared patterns ofOP, OF, and screening for OP by gender in CRCS. Given the gender disparities in the rates ofOP and OF, we used data from the National Health Interview Survey (NHIS) and the National Hospital Discharge Survey (NHDS) to assess the ratio ofOF in females and males in general population. RESULTS: Forty-seven percent of females and 15% ofmen CRCS had OP claims. Female CRCS were more likely than males to have OP (HR = 4.76 [3.77-6.01], p < 0.0001) and OF (HR = 2.64 [2.04-3.42], p < 0.0001). In the general population, the female to male ratio ofOF was 1.67 as opposed to 2.90 in CRCS, indicating a significantly larger gender disparity ofOF in CRCS (p < 0.001). Only 7% ofmen and 27% ofwomen CRCS had OP screening. CONCLUSION: Despite a low rate ofOP screening, the gender disparity ofOF in CRCS is more pronounced than the general population. These findings provide an impetus for studying OP and OF in CRCS.
Authors: M C Nevitt; B Ettinger; D M Black; K Stone; S A Jamal; K Ensrud; M Segal; H K Genant; S R Cummings Journal: Ann Intern Med Date: 1998-05-15 Impact factor: 25.391
Authors: Christy G Woolcott; Lynne R Wilkens; Abraham M Y Nomura; Ronald L Horst; Marc T Goodman; Suzanne P Murphy; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-01 Impact factor: 4.254
Authors: J R Curtis; A J Taylor; R S Matthews; M N Ray; D J Becker; L C Gary; M L Kilgore; M A Morrisey; K G Saag; A Warriner; E Delzell Journal: Osteoporos Int Date: 2009-01-29 Impact factor: 4.507
Authors: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts Journal: J Clin Oncol Date: 2003-12-09 Impact factor: 44.544
Authors: Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2016-06-02 Impact factor: 508.702